Nordhoff Sonja, Cerezo-Gálvez Silvia, Feurer Achim, Hill Oliver, Matassa Victor G, Metz Günther, Rummey Christian, Thiemann Meinolf, Edwards Paul J
Medicinal Chemistry, Santhera Pharmaceuticals, Im Neuenheimer Feld 518-519, D-69120 Heidelberg, Germany.
Bioorg Med Chem Lett. 2006 Mar 15;16(6):1744-8. doi: 10.1016/j.bmcl.2005.11.103. Epub 2006 Jan 11.
The co-crystal structure of beta-phenethylamine fragment inhibitor 5 bound to DPP-IV revealed that the phenyl ring occupied the proline pocket of the enzyme. This finding provided the basis for a general hypothesis of a reverse binding mode for beta-phenethylamine-based DPP-IV inhibitors. Novel inhibitor design concepts that obviate substrate-like structure-activity relationships (SAR) were thereby enabled, and novel, potent inhibitors were discovered.
与二肽基肽酶-IV(DPP-IV)结合的β-苯乙胺片段抑制剂5的共晶体结构表明,苯环占据了该酶的脯氨酸口袋。这一发现为基于β-苯乙胺的DPP-IV抑制剂的反向结合模式这一普遍假设提供了依据。由此开启了摒弃类似底物的构效关系(SAR)的新型抑制剂设计理念,并发现了新型强效抑制剂。